The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.
The Epidemiology of Sepsis in the United States from 1979 through 2000
Open accessAbstract
BACKGROUND: Sepsis represents a substantial health care burden, and there is limited epidemiologic information about the demography of sepsis or about the temporal changes in its incidence and outcome. We investigated the epidemiology of sepsis in the United States, with specific examination of race and sex, causative organisms, the disposition of patients, and the incidence and outcome. METHODS: We analyzed the occurrence of sepsis from 1979 through 2000 using a nationally representative sample of all nonfederal acute care hospitals in the United States. Data on new cases were obtained from hospital discharge records coded according to the International Classification of Diseases, Ninth Revision, Clinical Modification. RESULTS: Review of discharge data on approximately 750 million hospitalizations in the United States over the 22-year period identified 10,319,418 cases of sepsis. Sepsis was more common among men than among women (mean annual relative risk, 1.28 [95 percent confidence interval, 1.24 to 1.32]) and among nonwhite persons than among white persons (mean annual relative risk, 1.90 [95 percent confidence interval, 1.81 to 2.00]). Between 1979 and 2000, there was an annualized increase in the incidence of sepsis of 8.7 percent, from about 164,000 cases (82.7 per 100,000 population) to nearly 660,000 cases (240.4 per 100,000 population). The rate of sepsis due to fungal organisms increased by 207 percent, with gram-positive bacteria becoming the predominant pathogens after 1987. The total in-hospital mortality rate fell from 27.8 percent during the period from 1979 through 1984 to 17.9 percent during the period from 1995 through 2000, yet the total number of deaths continued to increase. Mortality was highest among black men. Organ failure contributed cumulatively to mortality, with temporal improvements in survival among patients with fewer than three failing organs. The average length of the hospital stay decreased, and the rate of discharge to nonacute care medical facilities increased. CONCLUSIONS: The incidence of sepsis and the number of sepsis-related deaths are increasing, although the overall mortality rate among patients with sepsis is declining. There are also disparities among races and between men and women in the incidence of sepsis. Gram-positive bacteria and fungal organisms are increasingly common causes of sepsis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“This approach follows the methods validated by many studies on the epidemiology of sepsis26, 27, 28, 29 and was used by Rudd and colleagues.10”
From Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050 (2024) · cites this paper as [28]
In the citing paper
“This trend continued with a greater than 200% increase from 1979 to 2000.23”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [23]
In the citing paper
“McNeil et al. (154) published an analysis of trends in infectious disease mortality in the United States and found a dramatic increase in multiple-cause mortality due to mycoses, from 1,557 deaths in 1980 to 6,534 deaths in 1997; the majority of these mycoses-related deaths were associated with Candida , Aspergillus , and Cryptococcus sp. infection.”
From Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) · cites this paper as [154]
In the citing paper
“At the same time, they showed an almost exponential increase in the mortality rates associated with IA, with a 357% increase in mortality between 1980 and 1996.”
From Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) · cites this paper as [154]
In the citing paper
“Previously, McNeil et al. (154) demonstrated that mortality rates associated with IC increased steadily from 1980 to a peak in 1989, followed by a gradual decline through 1996.”
From Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) · cites this paper as [154]
In the citing paper
“These data are directly comparable to those of McNeil et al. (154) and extend the data reported in that study beyond 1996 to the year 2003.”
From Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) · cites this paper as [154]
In the citing paper
“Again, the limitations of such data are well known, most notably the lack of validation of the mycotic infection and the failure to clinically diagnose IA and IC, resulting in an underestimation of mortality (154).”
From Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) · cites this paper as [154]
In the citing paper
“As stated by McNeil and colleagues (154), mortality associated with invasive mycoses is best represented by multiplecause-of-death data, which capture any mention of the mycotic disease on the death certificate.”
From Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) · cites this paper as [154]
In the citing paper
“Although this approach provides a much more generalizable sample of U.S. hospitals than many other methods of surveillance, it is likely to underestimate both incidence and mortality because of miscoding of IC, use of codes not captured by the analysis, or failure to code the infection at all (79, 154).”
From Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) · cites this paper as [154]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., BALK, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · CHEST Journal · doi:10.1378/chest.101.6.1644 · Cited by 13,317
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Bernard, G. R., Vincent, J., Laterre, P., LaRosa, S. P., Dhainaut, J.-F., Lopez-Rodriguez, A., Steingrub, J. S., Garber, G. E., Helterbrand, J. D., Ely, E. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441001 · Cited by 6,124
Rising Incidence of Hepatocellular Carcinoma in the United States
El‐Serag, H. B., & Mason, A. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401001 · Cited by 2,865
The Natural History of the Systemic Inflammatory Response Syndrome (SIRS)
Rangel-Frausto, M. S., Pittet, D., Costigan, M., Hwang, T., Davis, C. S., & Wenzel, R. P. (1995) · JAMA · doi:10.1001/jama.273.2.117 · Cited by 2,090
High-Dose Antithrombin III in Severe Sepsis
Warren, B., Eid, A. A., Singer, P., Pillay, S., Carl, P., Novák, I., Chalupa, P., Atherstone, A., Pénzes, I., Kübler, A., et al. (2001) · JAMA · doi:10.1001/jama.286.15.1869 · Cited by 1,422
Parrillo, J. E., Parker, M. M., Natanson, C., Suffredini, A. F., Danner, R. L., Cunnion, R. E., & Ognibene, F. P. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-3-227 · Cited by 1,188
Secular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990
Beck‐Sagué, C. M., Jarvis, W. R., & System, N. N. I. S. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.5.1247 · Cited by 1,140
Incidence, Risk Factors, and Outcome of Severe Sepsis and Septic Shock in Adults
Brun‐Buisson, C. (1995) · JAMA · doi:10.1001/jama.274.12.968 · Cited by 1,079
Treating Patients with Severe Sepsis
Wheeler, A. P., & Bernard, G. R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901213400307 · Cited by 992
Flagged first, then by citations
1 of the 48 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- 1990, MMWR Morb Mortal Wkly Rep, 39, 31
- Eaton S, 2002, Am J Respir Crit Care Med, 165, A471
Cited by
Sorted by citations
Items 901–1,000 of 1,032
A Comparative Review of Equine SIRS, Sepsis, and Neutrophils
Sheats, M. K. (2019) · Frontiers in Veterinary Science · doi:10.3389/fvets.2019.00069 · Cited by 97
Ren, Y., Zhang, L., Xu, F., Han, D., Zheng, S., Zhang, F., Li, L., Wang, Z., Lyu, J., & Yin, H. (2022) · BMC Pulmonary Medicine · doi:10.1186/s12890-021-01809-8 · Cited by 90
Zilberberg, M. D., & Shorr, A. F. (2008) · BMC Health Services Research · doi:10.1186/1472-6963-8-242 · Cited by 90
Sinnollareddy, M., Roberts, M. S., Lipman, J., & Roberts, J. A. (2012) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2012.05715.x · Cited by 90
Corona, A., Bertolini, G., Lipman, J., Wilson, A. P. R., & Singer, M. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq088 · Cited by 90
Mouse Eosinophils Possess Potent Antibacterial Properties In Vivo
Linch, S. N., Kelly, A. M., Danielson, E. T., Pero, R. S., Lee, J. J., & Gold, J. A. (2009) · Infection and Immunity · doi:10.1128/iai.00306-09 · Cited by 90
Treatment options of invasive fungal infections in adults
Marchetti, O., Eggimann, P., Pittet, D., Glauser, M., & Calandra, T. (2006) · Swiss Medical Weekly · doi:10.4414/smw.2006.11392 · Cited by 90
Norrby‐Teglund, A., Haque, K. N., & Hammarström, L. L. G. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01726.x · Cited by 89
Outcomes of treatment for hematogenous Staphylococcus aureus vertebral osteomyelitis in the MRSA ERA
Livorsi, D. J., Daver, N. G., Atmar, R. L., Shelburne, S. A., White, A. C., & Musher, D. M. (2008) · Journal of Infection · doi:10.1016/j.jinf.2008.04.012 · Cited by 89
Profile of the Risk of Death After Septic Shock in the Present Era
Pavon, A., Binquet, C., Kara, F., Martinet, O., Ganster, F., Navellou, J.-C., Castelain, V., Barraud, D., Cousson, J., Louis, G., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31829a6e89 · Cited by 89
Supplement: Trends in invasive Candida infections and their treatment: focus on echinocandins
Lewis, R. E. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990902990817 · Cited by 89
Steinberg, J. M., Halter, J. M., Schiller, H. J., Gatto, L. A., Carney, D. E., Lee, H., Golub, L. M., & Nieman, G. F. (2005) · Shock · doi:10.1097/01.shk.0000180619.06317.2c · Cited by 89
An alternate pathophysiologic paradigm of sepsis and septic shock
Kumar, A. (2013) · Virulence · doi:10.4161/viru.26913 · Cited by 90
Bloos, F., Sachse, S., Kortgen, A., Pletz, M. W., Lehmann, M. N., Straube, E., Riedemann, N. C., Reinhart, K., & Bauer, M. W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046003 · Cited by 88
Sridharan, P., & Chamberlain, R. S. (2013) · Surgical Infections · doi:10.1089/sur.2012.028 · Cited by 91
Singer, A. J., Taylor, M., Domingo, A., Ghazipura, S., Khorasonchi, A., Thode, H. C., & Shapiro, N. I. (2014) · Academic Emergency Medicine · doi:10.1111/acem.12444 · Cited by 88
Differences in immune response may explain lower survival among older men with pneumonia*
Reade, M. C., Yende, S. P., D’Angelo, G., Kong, L., Kellum, J. A., Barnato, A. E., Milbrandt, E. B., Dooley, C., Mayr, F., Weissfeld, L. A., et al. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819da853 · Cited by 88
Outcomes in Critically Ill Cancer Patients With Septic Shock of Pulmonary Origin
de Montmollin, É., Tandjaoui-Lambiotte, Y., Legrand, M., Lambert, J., Mokart, D., Kouatchet, A., Lemiale, V., Pène, F., Bruneel, F., Vincent, F., et al. (2013) · Shock · doi:10.1097/shk.0b013e3182866d32 · Cited by 88
Conde, K. A. P., Silva, E., Silva, C. O., Ferreira, E. M., Freitas, F. G. R., de Castro, I., Réa-Neto, Á., Grion, C. M. C., Moura, A. D., Lobo, S. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064790 · Cited by 88
Paxton, J. W. (2012) · InTech eBooks · doi:10.5772/1180 · Cited by 90
Epidemiology of sepsis in Catalonia: analysis of incidence and outcomes in a European setting
Yébenes, J. C., Ruiz‐Rodríguez, J. C., Ferrer, R., Clèries, M., Bosch, A., Lorencio, C., Rodriguez, A., Nuvials, X., Martín‐Loeches, I., Artigas, A., et al. (2017) · Annals of Intensive Care · doi:10.1186/s13613-017-0241-1 · Cited by 88
Luzzaro, F., Ortisi, G., Larosa, M., Drago, M., Brigante, G., & Gesu, G. P. (2011) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.10.016 · Cited by 87
Early recognition and management of sepsis in adults: the first six hours.
Gauer, R. L. (2013) · PubMed · Cited by 87
Pang, J., Hu, P., Wang, S., Xu, X., Xu, F., Wang, Q., Chen, Y., Barton, L. A., Chen, Y., Zhang, Y., et al. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.03.015 · Cited by 88
Empagliflozin Suppresses Inflammation and Protects Against Acute Septic Renal Injury
Maayah, Z. H., Ferdaoussi, M., Takahara, S., Soni, S., & Dyck, J. R. B. (2020) · Inflammopharmacology · doi:10.1007/s10787-020-00732-4 · Cited by 87
Pathogenetic mechanisms of septic cardiomyopathy
Wang, R., Xu, Y., Fang, Y., Wang, C., Xue, Y., Wang, F., Jin, C. S., Ren, H., Wang, J., Guo, W., et al. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30527 · Cited by 87
Knockout of Mkp-1 Enhances the Host Inflammatory Responses to Gram-Positive Bacteria
Wang, X., Meng, X., Kuhlman, J. R., Nelin, L. D., Nicol, K. K., English, B. K., & Liu, Y. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.5312 · Cited by 87
The Relationship between Hospital Volume and Mortality in Severe Sepsis
Gaieski, D. F., Edwards, J. M., Kallan, M. J., Mikkelsen, M. E., Goyal, M. K., & Carr, B. G. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201402-0289oc · Cited by 87
Antibiotic resistance in sepsis patients: Evaluation and recommendation of antibiotic use
Pradipta, I. S., Sodik, D. C., Parwati, I., Lestari, K., Halimah, E., Diantini, A., & Abdulah, R. (2013) · North American Journal of Medical Sciences · doi:10.4103/1947-2714.114165 · Cited by 87
Neutrophils and Intravascular Immunity in the Liver during Infection and Sterile Inflammation
McDonald, B., & Kubes, P. (2011) · Toxicologic Pathology · doi:10.1177/0192623311427570 · Cited by 89
Coletta, C., Módis, K., Oláh, G., Brunyánszki, A., Herzig, D. S., Sherwood, E. R., Ungvari, Z. I., & Szabó, C. (2014) · Critical Care · doi:10.1186/s13054-014-0511-3 · Cited by 87
Ghanem‐Zoubi, N., Vardi, M., Laor, A., Weber, R., & Bitterman, H. (2011) · Critical Care · doi:10.1186/cc10102 · Cited by 87
Effects of intra-abdominal sepsis on atherosclerosis in mice
Kaynar, A. M., Yende, S. P., Zhu, L., Frederick, D. R., Chambers, R., Burton, C. L., Carter, M., Stolz, D. B., Agostini, B., Gregory, A. D., et al. (2014) · Critical Care · doi:10.1186/s13054-014-0469-1 · Cited by 87
Chen, Q., Zhang, K., Jin, Y., Zhu, T., Cheng, B., Shu, Q., & Fang, X. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201211-1967oc · Cited by 87
Is metformin poised for a second career as an antimicrobial?
Malik, F. R., Mehdi, S. F., Ali, H., Patel, P., Basharat, A., Kumar, A., Ashok, F., Stein, J., Brima, W., Malhotra, P., et al. (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2975 · Cited by 89
The Hsp90 Co-Chaperone Sgt1 Governs Candida albicans Morphogenesis and Drug Resistance
Shapiro, R. S., Zaas, A. K., Betancourt-Quiroz, M., Perfect, J. R., & Cowen, L. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044734 · Cited by 86
Beal, S. G., Ciurca, J., Smith, G., John, J., Lee, F., Doern, C. D., & Gander, R. M. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.01889-13 · Cited by 86
Tillack, K., Naegele, M., Haueis, C., Schippling, S., Wandinger, K., Martinꝉ, R., & Sospedra, M. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.05.004 · Cited by 88
Akbar, U., Dham, B. S., He, Y., Hack, N. K., Wu, S. S., Troche, M. S., Tighe, P. J., Nelson, E., Friedman, J. H., & Okun, M. S. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.06.020 · Cited by 86
Inácio, J., Flores, O., & Spencer‐Martins, I. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00514-07 · Cited by 86
A survey of Canadian intensivists' resuscitation practices in early septic shock
McIntyre, L., Hébert, P. C., Fergusson, D. A., Cook, D. J., Aziz, A., & the Canadian Critical Care Trials Group (2007) · Critical Care · doi:10.1186/cc5962 · Cited by 86
Chalupka, A. N., & Talmor, D. S. (2011) · Critical Care Clinics · doi:10.1016/j.ccc.2011.09.003 · Cited by 86
Increase in bloodstream infections in Finland, 1995–2002
Skogberg, K., Lyytikäinen, O., Ruutu, P., Ollgren, J. P., & Nuorti, J. P. (2007) · Epidemiology and Infection · doi:10.1017/s0950268807008138 · Cited by 86
Treatment with GITR agonistic antibody corrects adaptive immune dysfunction in sepsis
Scumpia, P. O., Delano, M. J., Kelly‐Scumpia, K. M., Weinstein, J. S., Wynn, J. L., Winfield, R. D., Xia, C., Chung, C. S., Ayala, A., Atkinson, M. A., et al. (2007) · Blood · doi:10.1182/blood-2007-04-087171 · Cited by 86
Improved survival of children with sepsis and purpura: effects of age, gender, and era
Maat, M., Buysse, C., Emonts, M., Spanjaard, L., Joosten, K. F. M., de Groot, R., & Hazelzet, J. A. (2007) · Critical Care · doi:10.1186/cc6161 · Cited by 86
Objective Sepsis Surveillance Using Electronic Clinical Data
Rhee, C., Kadri, S. S., Huang, S. S., Murphy, M. V., Li, L., Platt, R. G., & Klompas, M. (2015) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2015.264 · Cited by 86
Goodwin (2016) · doi:10.1016/j.chest.2016.07.004 · Cited by 86
Effects of Drotrecogin Alfa (Activated) in Human Endotoxemia
Kalil, A. C., Coyle, S. M., Um, J. Y., LaRosa, S. P., Turlo, M. A., Calvano, S. E., Sundin, D. P., Nelson, D. R., & Lowry, S. F. (2004) · Shock · doi:10.1097/01.shk.0000116778.27924.79 · Cited by 86
Glucocorticoid resistance as a major drive in sepsis pathology
Dendoncker, K., & Libert, C. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.04.002 · Cited by 85
Avecillas, J. F., Freire, A. X., & Arroliga, A. C. (2006) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2006.06.001 · Cited by 85
Mending Leaky Blood Vessels: The Angiopoietin-Tie2 Pathway in Sepsis
David, S., Kümpers, P., Slyke, P. V., & Parikh, S. M. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.201061 · Cited by 87
Sepsis and Septic Shock Strategies
Armstrong, B., Betzold, R., & May, A. K. (2017) · Surgical Clinics of North America · doi:10.1016/j.suc.2017.07.003 · Cited by 88
Cuenca, A. G., Delano, M. J., Kelly‐Scumpia, K. M., Moldawer, L. L., & Efron, P. A. (2010) · Current Protocols in Immunology · doi:10.1002/0471142735.im1913s91 · Cited by 85
Al‐Ostad, G., Kezouh, A., Spence, A. R., & Abenhaim, H. A. (2015) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.12710 · Cited by 85
Fish oil in the critically ill: from experimental to clinical data
Mayer, K., Schaefer, M. B., & Seeger, W. (2006) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000214573.75062.0a · Cited by 85
Seifert, H., Aurbach, U., Stefanik, D., & Cornely, O. A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01217-06 · Cited by 85
Drug Disposition in Pathophysiological Conditions
Gandhi, A. S., Moorthy, B., & Ghose, R. (2012) · Current Drug Metabolism · doi:10.2174/138920012803341302 · Cited by 85
Raghunathan, K., Bonavia, A. S., Nathanson, B. H., Beadles, C. A., Shaw, A., Brookhart, M. A., Miller, T. E., & Lindenauer, P. K. (2015) · Anesthesiology · doi:10.1097/aln.0000000000000861 · Cited by 84
Finfer, S. R., Ranieri, V. M., Thompson, B., Barie, P. S., Dhainaut, J.-F., Douglas, I. S., Gårdlund, B., Marshall, J. C., & Rhodes, A. (2008) · Intensive Care Medicine · doi:10.1007/s00134-008-1266-6 · Cited by 84
Kempker, J. A., & Martin, G. S. (2020) · The Lancet · doi:10.1016/s0140-6736(19)33065-x · Cited by 84
Self-citationHöcherl, K., Schmidt, C. G., Kurt, B., & Bucher, M. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90607.2008 · Cited by 84
Gebert, S., Siegel, D., & Wellinghausen, N. (2008) · Journal of Infection · doi:10.1016/j.jinf.2008.07.013 · Cited by 84
Hagiwara, S., Iwasaka, H., Hasegawa, A., Koga, H., & Noguchi, T. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e318180b3ba · Cited by 84
Improved detection of blood stream pathogens by real-time PCR in severe sepsis
Lehmann, L. E., Hunfeld, K., Steinbrucker, M., Brade, V., Book, M., Seifert, H., Bingold, T. M., Hoeft, A., Wissing, H., & Stüber, F. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1608-z · Cited by 84
Pérez, E. R. F., Salman, S. S., Pendem, S., & Farmer, J. C. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000182479.63108.cd · Cited by 84
Lillehoj, P. B., Kaplan, C. W., He, J. G., Shi, W., & Ho, C. (2013) · SLAS TECHNOLOGY · doi:10.1177/2211068213495207 · Cited by 84
Davis, J. S., Cheng, A. C., McMillan, M., Humphrey, A. B., Stephens, D. P., & Anstey, N. M. (2011) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2011.tb03088.x · Cited by 73
The Role of Plasmapheresis in Critical Illness
Nguyen, T. C., Kiss, J. E., Goldman, J. R., & Carcillo, J. A. (2012) · Critical Care Clinics · doi:10.1016/j.ccc.2012.04.009 · Cited by 83
Purtle, S. W., Moromizato, T., McKane, C. K., Gibbons, F. K., & Christopher, K. B. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000118 · Cited by 83
The Surviving Sepsis Campaign: A History and a Perspective
Marshall, J. C., Dellinger, R. P., & Levy, M. (2010) · Surgical Infections · doi:10.1089/sur.2010.024 · Cited by 86
Boonmee, P., Ruangsomboon, O., Limsuwat, C., & Chakorn, T. (2020) · Western Journal of Emergency Medicine · doi:10.5811/westjem.2020.7.47405 · Cited by 90
dos Santos, C. C., Amatullah, H., Vaswani, C. M., Maron‐Gutierrez, T., Kim, M., Mei, S. H. J., Szászi, K., Monteiro, A. P. T., Varkouhi, A. K., Herreroz, R., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.04216-2020 · Cited by 83
Huang, W., Liu, Y., Li, L., Zhang, R., Liu, W., Wu, J., Mao, E., & Tang, Y.-Q. (2011) · Inflammation · doi:10.1007/s10753-011-9325-5 · Cited by 83
Felton, T., Roberts, J. A., Lodise, T. P., Guilder, M. V., Boselli, E., Neely, M. N., & Hope, W. W. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02664-14 · Cited by 83
Slatore, C. G., Cecere, L. M., LeTourneau, J. L., O'Neil, M. E., Duckart, J. P., Wiener, R. S., Farjah, F., & Cooke, C. R. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.0846 · Cited by 83
Shin, T. G., Jo, I. J., Choi, D. J., Kang, M. J., Jeon, K., Suh, G. Y., Sim, M. S., Lim, S. Y., Song, K. J., & Jeong, Y. K. (2013) · Critical Care · doi:10.1186/cc13047 · Cited by 86
Kuhn, S.-O., Meissner, K., Mayes, L. M., & Bartels, K. (2018) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000549 · Cited by 82
Asymmetric Dimethylarginine, Endothelial Nitric Oxide Bioavailability and Mortality in Sepsis
Davis, J. S., Darcy, C. J., Yeo, T. W., Jones, C. E., McNeil, Y., Stephens, D. P., Celermajer, D. S., & Anstey, N. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017260 · Cited by 82
Ogawa, Y., Yamakawa, K., Ogura, H., Kiguchi, T., Mohri, T., Nakamori, Y., Kuwagata, Y., Shimazu, T., Hamasaki, T., & Fujimi, S. (2012) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e3182516ab5 · Cited by 82
Population-Based Epidemiology of Sepsis in a Subdistrict of Beijing
Zhou, J., Tian, H., Du, X., Xi, X., An, Y., Duan, M., Weng, L., & Du, B. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002414 · Cited by 82
Knoop, S. T., Skrede, S., Langeland, N., & Flaatten, H. K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187990 · Cited by 82
Silencing of Fas-associated Death Domain Protects Mice from Septic Lung Inflammation and Apoptosis
Matsuda, N., Yamamoto, S., Takano, K.-I., Kageyama, S., Kurobe, Y., Yoshihara, Y., Takano, Y., & Hattori, Y. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200804-534oc · Cited by 82
Jia, S. H., Parodo, J. C., Kapùs, A., Rotstein, O. D., & Marshall, J. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706462200 · Cited by 83
Cao, Y., Tu, Y., Chen, X. '., Wang, B., Zhong, Y., & Liu, M. (2010) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2010.11.011 · Cited by 82
Role of Complement in Multiorgan Failure
Rittirsch, D., Redl, H. R., & Huber-Lang, M. S. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/962927 · Cited by 85
Association of γδ T Cells with Disease Severity and Mortality in Septic Patients
Andreu‐Ballester, J. C., Tormo-Calandín, C., García‐Ballesteros, C., Perez-Griera, J., Amigó, V., Almela-Quilis, A., del Castillo, J. R., Peñarroja-Otero, C., & Ballester, F. (2013) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00752-12 · Cited by 82
Starr, M. E., Ueda, J., Takahashi, H., Weiler-Guettler, H., Esmon, C. T., Evers, B. M., & Saitō, H. (2010) · Blood · doi:10.1182/blood-2009-10-246678 · Cited by 82
Chronic Sepsis Mortality Characterized by an Individualized Inflammatory Response
Osuchowski, M. F., Welch, K. B., Yang, H., Siddiqui, J., & Remick, D. G. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.623 · Cited by 82
Choice of Fluid Therapy in the Initial Management of Sepsis, Severe Sepsis, and Septic Shock
Chang, R., & Holcomb, J. B. (2016) · Shock · doi:10.1097/shk.0000000000000577 · Cited by 83
Wu, C., Lee, H., Lee, N., Shih, H., Ko, N., Wang, L., & Ko, W. (2006) · PubMed · Cited by 82
Lee, J. S., Choi, H. S., Ko, Y. G., & Yun, D. H. (2013) · Clinical Nutrition · doi:10.1016/j.clnu.2013.01.007 · Cited by 81
Non-coding RNA: a potential biomarker and therapeutic target for sepsis
Zhang, T., Li, D., Xia, J., Wu, Q., Wen, R., Yang, N., & Liu, C. (2017) · Oncotarget · doi:10.18632/oncotarget.21766 · Cited by 82
Variations in Organism-Specific Severe Sepsis Mortality in the United States
Ani, C., Farshidpanah, S., Stewart, A. B., & Nguyen, H. B. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000555 · Cited by 81
Substrate utilization in sepsis and multiple organ failure
Tappy, L., & Chioléro, R. L. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000278062.28122.a4 · Cited by 81
Improved diagnostic approaches to infection/sepsis detection
Davis, B. H. (2005) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.5.2.193 · Cited by 81
Vogel, T. R., Dombrovskiy, V. Y., & Lowry, S. F. (2010) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2010.08.009 · Cited by 81
Clinical sepsis and septic shock—definition, diagnosis and management principles
Vincent, J. (2008) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-008-0343-1 · Cited by 81
Knuefermann, P., Schwederski, M., Velten, M., Krings, P., Ehrentraut, H., Rüdiger, M., Boehm, O., Fink, K., Dreiner, U., Grohé, C., et al. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn011 · Cited by 81
Kanji, S., Perreault, M. M., Chant, C. A., Williamson, D. R., & Burry, L. D. (2007) · Intensive Care Medicine · doi:10.1007/s00134-007-0555-9 · Cited by 81
Berbée, J. F. P., van der Hoogt, C. C., Kleemann, R., Schippers, E. F., Kitchens, R. L., van Dissel, J. T., Bakker‐Woudenberg, I. A. J. M., Havekes, L. M., & Rensen, P. C. N. (2006) · The FASEB Journal · doi:10.1096/fj.05-5639fje · Cited by 81
Metadata
- Authors
- Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M.
- Affiliations
- Emory University (US)
- Centers for Disease Control and Prevention (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-04-17
- Volume
- 348
- Issue
- 16
- Pages
- 1546-1554
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2145577370
- Cited by
- 5,841
- References
- 48
- Citations by year
- 2026: 67 · 2025: 128 · 2024: 149 · 2023: 168 · 2022: 167 · 2021: 253 · 2020: 231 · 2019: 211 · 2018: 226 · 2017: 329 · 2016: 292 · 2015: 341 · 2014: 381 · 2013: 436 · 2012: 365
- FWCI
- 123.48
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- UKnowledge (University of Kentucky) (submittedVersion)
- Funders
- National Institute on Alcohol Abuse and Alcoholism (AA R01-11660, R01AA011660)
- National Heart, Lung, and Blood Institute (K23HL067739, HL K23-67739)
- National Center for Research Resources (L30 RR020488)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and Maternal Infections
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Keywords
- PSIS, sepsis incidence, sepsis mortality, temporal trends, racial disparities, sex differences, Gram-positive bacteria, fungal infection, sepsis pathogens, organ failure, length of hospital stay, hospital discharge disposition, Black men, hospital discharge data, acute care hospitals, healthcare burden
- MeSH terms
- Female, Humans, Male, Middle Aged, Multiple Organ Failure, Sex Factors, United States, Incidence, Survival Rate, Hospital Mortality, Sepsis, Racial Groups
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
